Font size
  • A-
  • A
  • A+
Site color
  • R
  • A
  • A
  • A
Skip to main content
RCPE
  • Home
  • Browse content
    ★ Latest ★ Evening Medical Updates (EMUs) Symposia International Medical Updates (IMUs) Careers & Training 🎧 Podcasts Modules/Cases 🔓 Open access Delegate-only Courses Specialty tags
  • 🔎 Search content
  • RCPE Live
  • RCPE websites
    RCPE Website Events Calendar JRCPE (Journal) 🎧 RCPE Podcasts
  • More
Guest
Log in
Home Browse content Collapse Expand
★ Latest ★ Evening Medical Updates (EMUs) Symposia International Medical Updates (IMUs) Careers & Training 🎧 Podcasts Modules/Cases 🔓 Open access Delegate-only Courses Specialty tags
🔎 Search content RCPE Live RCPE websites Collapse Expand
RCPE Website Events Calendar JRCPE (Journal) 🎧 RCPE Podcasts
Pharmacology Events
Skip JRCPE Articles
JRCPE Articles
Volume 53: Issue 2: 2023

Effects of metformin on glycaemic variability in combination with insulin in overweight/obese patients with type 1 diabetes

Utility of denosumab therapy in management of severe hypercalcaemia caused by primary hyperparathyroidism – Case report with review of literature

Insulin biobetters and biosimilars in clinical practice

Volume 53: Issue 1: 2023

Quinine overdose: Not quite gin and tonic

Volume 52: Issue 4: 2022

Challenges in managing patients on anticoagulation: Thrombocytopenia, resumption after bleeding and recurrent thrombosis

Volume 52: Issue 2: 2022

Too much of a good thing: A case series of rare yet pertinent causes of hypercalcaemia and acute kidney injury

Tenofovir-induced distal renal tubular acidosis: A rare cause of recurrent hypokalaemic paralysis

Volume 52: Issue 1: 2022

The use of tacrolimus in the management of checkpoint inhibitor immunotherapy-induced hepatitis

Nodules, nodes and non-functioning macrophages: A risk with ibrutinib therapy

Volume 51: Issue 4: 2021

Drug-induced hepatocellular injury due to herbal supplement ashwagandha

Volume 51: Issue 3: 2021

Safety of long-term use of four common conventional disease modifying anti-rheumatic drugs in rheumatoid arthritis

Why so blue? The blood gas has the clue…

Letter to the Editor: Levetiracetam-induced systemic lupus erythematosus or simply a drug-induced rash?

Volume 51: Issue 2: 2021

The mystery of ‘saturation gap’ and falsely normal G6PD: a case of primaquine-induced haemolysis in Plasmodium vivax malaria infection

Volume 51: Issue 1: 2021

New saviour for an old problem: Omecamtiv mecarbil for systolic heart failure

Levetiracetam-induced systemic lupus erythematosus

Amiodarone lung: under recognised but not forgotten

Volume 50: Issue 4: 2020

Normal dose paracetamol in muscular dystrophy patients – is it normal?

Anti-tubercular therapy causing Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome

Volume 50: Issue 3: 2020

Tenofovir-induced delayed nephro-osteo toxicity

Volume 50: Issue 2: 2020

Editorial: Hydroxychloroquine and coronavirus disease 2019

Is the Medicines and Healthcare products Regulator Agency (MHRA) guidance on sodium valproate acceptable to women of childbearing age?

Emerging pharmacotherapy for COVID-19

Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?

Improving intravenous fluid prescribing

Volume 50: Issue 1: 2020

Drug-induced rheumatic syndromes: the need to be aware

Old drug, new trick: colchicine for cardiovascular diseases

Volume 49: Issue 3: 2019

The use of adenosine in the assessment of stable coronary heart disease

Incidence of acute bronchospasm during systemic adenosine administration for coronary angiography

The Mary Walker effect: Mary Broadfoot Walker

Volume 49: Issue 1: 2019

Levodopa-induced myocardial infarction in a patient with Parkinson’s disease and severe coronary artery disease

Volume 48: Issue 3: 2018

Possible modulation of concurrent Parkinson’s disease in the management of metastatic GIST: a review of two cases

CANTOS – is selective targeting of inflammation in atherosclerosis enough?

The last apothecary: Eric Knott (1896–1993) and 20th-century pharmacy in Scotland

Volume 48: Issue 2: 2018

Drug induced thrombotic microangiopathy caused by levofloxacin

Volume 48: Issue 1: 2018

Addressing prescription discrepancies in renal patients: a prospective audit

JRCPE Archive

Education Portal

  1. Tags
  2. Pharmacology

Pharmacology

Related tags:
  • Cardiology
  • Geriatric Medicine
  • Haematology
  • Neurology
  • Diabetes
  • Oncology
  • Parkinson's
  • Dermatology
  • Emergency
  • Public Health
  • Gastroenterology
  • Endocrinology
  • Global Health
  • Renal
  • Infectious Diseases
  • Psychiatry / Psychological
  • Allergy / Immunology
  • Hepatology
  • Respiratory
  • COVID-19
  • Digital Health
  • 2020
  • Toxicology
  • Palliative
  • 2019
  • 2021
  • more...
  • less...

Events & e-learning

  • Changing times for tuberculosis: building on Sir John Crofton's legacy
    Category: Respiratory

Contact us

Follow us

Contact site support
Guest (Log in)
Log in help
Privacy Statement
Powered by Moodle

This theme was developed by

Conecti.me
©2023 Royal College of Physicians of Edinburgh
A charity registered in Scotland no. SC009465